The Certified Medication Assisted Treatment Advocate (CMA) course was developed by the MAT patient advocates at the National Alliance for Medication Assisted Recovery (NAMA Recovery) and first offered in 2004 as a pre-conference session of the AATOD Conference in Orlando, Florida.
This training is designed for non-clinicians and provides a basic understanding of the science of opioid use disorder and the use of FDA medications to treat it (i.e. methadone, buprenorphine, and naltrexone). Regulations at the federal, state and local levels are explained in simple terms for non-policy makers, and the intersection of deemed OTP accreditors (CARF International, The Joint Commission, Council on Accreditation, National Commission on Correctional Healthcare, and a couple of state-specific departments).
The course involves 8 hours of rigorous training and fulfills the training requirement for Certification as a Medication Assisted Treatment Advocate (CMA). The a registration fee of $50.00 includes the certification course, membership in NAMA Recovery, and the initial CMA certification.
This CMA Training Course is being offered as a Pre-Conference Session of the 2021 Conference of the American Association for the Treatment of Opioid Dependence (AATOD), originally scheduled to be held in Las Vegas, Nevada, on Saturday April 10, 2021 beginning at 9:00am *Pacific Time.*
NAMA Recovery thanks AATOD and the Department of Health and Human Services Nevada Division of Public and Behavioral Health (DPBH) for making this year's conference a reality, continuing to prioritize the CMA Training Course as an offering.